369 related articles for article (PubMed ID: 24402580)
1. Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets.
Furst DE; Emery P
Rheumatology (Oxford); 2014 Sep; 53(9):1560-9. PubMed ID: 24402580
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of USF2 in refractory rheumatoid arthritis and its regulation of proinflammatory cytokines in Th17 cells.
Hu D; Tjon EC; Andersson KM; Molica GM; Pham MC; Healy B; Murugaiyan G; Pochet N; Kuchroo VK; Bokarewa MI; Weiner HL
Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30639-30648. PubMed ID: 33203678
[TBL] [Abstract][Full Text] [Related]
3. Enhanced and persistent levels of interleukin (IL)-17⁺ CD4⁺ T cells and serum IL-17 in patients with early inflammatory arthritis.
Gullick NJ; Abozaid HS; Jayaraj DM; Evans HG; Scott DL; Choy EH; Taams LS
Clin Exp Immunol; 2013 Nov; 174(2):292-301. PubMed ID: 23815507
[TBL] [Abstract][Full Text] [Related]
4. IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation.
Corvaisier M; Delneste Y; Jeanvoine H; Preisser L; Blanchard S; Garo E; Hoppe E; Barré B; Audran M; Bouvard B; Saint-André JP; Jeannin P
PLoS Biol; 2012; 10(9):e1001395. PubMed ID: 23055831
[TBL] [Abstract][Full Text] [Related]
5. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.
Azizi G; Jadidi-Niaragh F; Mirshafiey A
Int J Rheum Dis; 2013 Jun; 16(3):243-53. PubMed ID: 23981743
[TBL] [Abstract][Full Text] [Related]
6. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics.
Osiri M; Wongpiyabovorn J; Sattayasomboon Y; Thammacharoenrach N
Clin Rheumatol; 2016 Jul; 35(7):1673-81. PubMed ID: 27188857
[TBL] [Abstract][Full Text] [Related]
8. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation.
Ye L; Jiang B; Deng J; Du J; Xiong W; Guan Y; Wen Z; Huang K; Huang Z
J Immunol; 2015 Jun; 194(11):5110-9. PubMed ID: 25917106
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis.
van Hamburg JP; Tas SW
J Autoimmun; 2018 Feb; 87():69-81. PubMed ID: 29254845
[TBL] [Abstract][Full Text] [Related]
10. Elevated circulating Th17 and follicular helper CD4(+) T cells in patients with rheumatoid arthritis.
Zhang Y; Li Y; Lv TT; Yin ZJ; Wang XB
APMIS; 2015 Aug; 123(8):659-66. PubMed ID: 25912557
[TBL] [Abstract][Full Text] [Related]
11. Effects of TNF inhibitor on innate inflammatory and Th17 cytokines in stimulated whole blood from rheumatoid arthritis patients.
Zivojinovic S; Pejnovic N; Sefik-Bukilica M; Kovacevic L; Soldatovic I; Bugarski D; Mojsilovic S; Damjanov N
Inflammopharmacology; 2012 Dec; 20(6):323-30. PubMed ID: 22733231
[TBL] [Abstract][Full Text] [Related]
12. The role of interleukin-17 in the pathogenesis of rheumatoid arthritis.
Gaffen SL
Curr Rheumatol Rep; 2009 Oct; 11(5):365-70. PubMed ID: 19772832
[TBL] [Abstract][Full Text] [Related]
13. The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy.
Roeleveld DM; Koenders MI
Cytokine; 2015 Jul; 74(1):101-7. PubMed ID: 25466295
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis.
Guo C; Hu F; Yi H; Feng Z; Li C; Shi L; Li Y; Liu H; Yu X; Wang H; Li J; Li Z; Wang XY
Ann Rheum Dis; 2016 Jan; 75(1):278-85. PubMed ID: 25371442
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic Transdifferentiation of Th17 Cells Contribute to Perpetuation of Rheumatoid Arthritis during Anti-TNF Treatment.
Andersson KM; Cavallini NF; Hu D; Brisslert M; Cialic R; Valadi H; Erlandsson MC; Silfverswärd S; Pullerits R; Kuchroo VK; Weiner HL; Bokarewa MI
Mol Med; 2015 Jun; 21(1):536-43. PubMed ID: 26062018
[TBL] [Abstract][Full Text] [Related]
16. Th17 cytokines and arthritis.
Lubberts E
Semin Immunopathol; 2010 Mar; 32(1):43-53. PubMed ID: 20127485
[TBL] [Abstract][Full Text] [Related]
17. The expanding role of IL-7 and thymic stromal lymphopoietin as therapeutic target for rheumatoid arthritis.
Pathak K
Expert Opin Ther Targets; 2014 May; 18(5):581-94. PubMed ID: 24641111
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses.
Bishu S; Su EW; Wilkerson ER; Reckley KA; Jones DM; McGeachy MJ; Gaffen SL; Levesque MC
Arthritis Res Ther; 2014 Feb; 16(1):R50. PubMed ID: 24513269
[TBL] [Abstract][Full Text] [Related]
19. Embracing novel cytokines in RA - complexity grows as does opportunity!
Hueber AJ; Asquith DL; McInnes IB; Miller AM
Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):479-87. PubMed ID: 20732646
[TBL] [Abstract][Full Text] [Related]
20. Targeting IL-17 and Th17 cells in rheumatoid arthritis.
Sarkar S; Fox DA
Rheum Dis Clin North Am; 2010 May; 36(2):345-66. PubMed ID: 20510238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
